Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells

26 Apr 2012

Abstract excerpt

Human embryonic stem cell (hESC)-derived dopaminergic (DA) neurons hold potential for treating Parkinson's disease (PD) through cell replacement therapy. Generation of DA neurons from hESCs has been achieved by coculture with the stromal cell line PA6, a source of stromal cell-derived inducing activity (SDIA). However, the factors produced by stromal cells that result in SDIA are largely undefined. We previously...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurogenesis and neuroplasticity mechanisms
Share to Pluripotent Stem Cells Research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22535492
DOI: 10.1002/jnr.23064

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cellsPMID 22535492Read ↗

Single Cell Gene Expression Analysis Reveals Human Stem Cell-Derived Graft Composition in a Cell Therapy Model of Parkinson’s DiseaseSemantic proximity Read ↗

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem CellsSemantic proximity Read ↗

Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.Semantic proximity Read ↗

Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.Semantic proximity Read ↗

Derivation of midbrain dopamine neurons from human embryonic stem cells.Semantic proximity Read ↗

Specification of a dopaminergic phenotype from adult human mesenchymal stem cells.Semantic proximity Read ↗

Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease.Semantic proximity Read ↗

Heparan sulfate Sulfatases are essential for patterning of human stem cell-derived midbrain dopaminergic neuronsSemantic proximity Read ↗

Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells.Semantic proximity Read ↗

Efficient Conversion of Spermatogonial Stem Cells to Phenotypic and Functional Dopaminergic Neurons via the PI3K/Akt and P21/Smurf2/Nolz1 Pathway.Semantic proximity Read ↗

Therapeutic effects of umbilical cord MSC-derived induced neuronal cells in a rat Parkinson's modelSemantic proximity Read ↗

In vitro assays for neural stem cell differentiation: induction of dopaminergic phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.